Highlights

[HEXTAR] YoY TTM Result on 2015-03-31 [#1]

Stock [HEXTAR]: HEXTAR GLOBAL BERHAD
Announcement Date 27-May-2015
Admission Sponsor -
Sponsor -
Financial Year 30-Sep-2015
Quarter 31-Mar-2015  [#1]
Profit Trend QoQ -     -17.53%    YoY -     -39.77%
Quarter Report


View:


Show?  YoY % Horiz. %

TTM Result
31/03/18 31/03/17 31/03/16 31/03/15 31/12/13 31/12/12 31/12/11 CAGR
Revenue 70,737 65,861 83,856 76,776 97,205 98,901 102,150 -5.71%
  YoY % 7.40% -21.46% 9.22% -21.02% -1.71% -3.18% -
  Horiz. % 69.25% 64.47% 82.09% 75.16% 95.16% 96.82% 100.00%
PBT -9,558 -24,664 -2,632 2,704 4,597 4,767 5,933 -
  YoY % 61.25% -837.08% -197.34% -41.18% -3.57% -19.65% -
  Horiz. % -161.10% -415.71% -44.36% 45.58% 77.48% 80.35% 100.00%
Tax -1,018 -419 -370 -897 -1,368 -755 -1,455 -5.55%
  YoY % -142.96% -13.24% 58.75% 34.43% -81.19% 48.11% -
  Horiz. % 69.97% 28.80% 25.43% 61.65% 94.02% 51.89% 100.00%
NP -10,576 -25,083 -3,002 1,807 3,229 4,012 4,478 -
  YoY % 57.84% -735.54% -266.13% -44.04% -19.52% -10.41% -
  Horiz. % -236.18% -560.14% -67.04% 40.35% 72.11% 89.59% 100.00%
NP to SH -10,576 -25,091 -3,002 1,807 3,229 4,012 4,478 -
  YoY % 57.85% -735.81% -266.13% -44.04% -19.52% -10.41% -
  Horiz. % -236.18% -560.32% -67.04% 40.35% 72.11% 89.59% 100.00%
Tax Rate - % - % - % 33.17 % 29.76 % 15.84 % 24.52 % -
  YoY % 0.00% 0.00% 0.00% 11.46% 87.88% -35.40% -
  Horiz. % 0.00% 0.00% 0.00% 135.28% 121.37% 64.60% 100.00%
Total Cost 81,313 90,944 86,858 74,969 93,976 94,889 97,672 -2.89%
  YoY % -10.59% 4.70% 15.86% -20.23% -0.96% -2.85% -
  Horiz. % 83.25% 93.11% 88.93% 76.76% 96.22% 97.15% 100.00%
Net Worth 72,061 80,539 124,262 0 90,595 91,249 80,582 -1.77%
  YoY % -10.53% -35.19% 0.00% 0.00% -0.72% 13.24% -
  Horiz. % 89.43% 99.95% 154.21% 0.00% 112.43% 113.24% 100.00%
Dividend
31/03/18 31/03/17 31/03/16 31/03/15 31/12/13 31/12/12 31/12/11 CAGR
Div 0 0 0 0 0 0 0 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/03/18 31/03/17 31/03/16 31/03/15 31/12/13 31/12/12 31/12/11 CAGR
Net Worth 72,061 80,539 124,262 0 90,595 91,249 80,582 -1.77%
  YoY % -10.53% -35.19% 0.00% 0.00% -0.72% 13.24% -
  Horiz. % 89.43% 99.95% 154.21% 0.00% 112.43% 113.24% 100.00%
NOSH 105,973 105,973 106,206 105,753 99,555 100,273 79,784 4.64%
  YoY % 0.00% -0.22% 0.43% 6.23% -0.72% 25.68% -
  Horiz. % 132.82% 132.82% 133.12% 132.55% 124.78% 125.68% 100.00%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -14.95 % -38.08 % -3.58 % 2.35 % 3.32 % 4.06 % 4.38 % -
  YoY % 60.74% -963.69% -252.34% -29.22% -18.23% -7.31% -
  Horiz. % -341.32% -869.41% -81.74% 53.65% 75.80% 92.69% 100.00%
ROE -14.68 % -31.15 % -2.42 % - % 3.56 % 4.40 % 5.56 % -
  YoY % 52.87% -1,187.19% 0.00% 0.00% -19.09% -20.86% -
  Horiz. % -264.03% -560.25% -43.53% 0.00% 64.03% 79.14% 100.00%
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/12/13 31/12/12 31/12/11 CAGR
RPS 66.75 62.15 78.96 72.60 97.64 98.63 128.03 -9.89%
  YoY % 7.40% -21.29% 8.76% -25.65% -1.00% -22.96% -
  Horiz. % 52.14% 48.54% 61.67% 56.71% 76.26% 77.04% 100.00%
EPS -9.98 -23.68 -2.83 1.71 3.24 4.00 5.61 -
  YoY % 57.85% -736.75% -265.50% -47.22% -19.00% -28.70% -
  Horiz. % -177.90% -422.10% -50.45% 30.48% 57.75% 71.30% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.6800 0.7600 1.1700 0.0000 0.9100 0.9100 1.0100 -6.13%
  YoY % -10.53% -35.04% 0.00% 0.00% 0.00% -9.90% -
  Horiz. % 67.33% 75.25% 115.84% 0.00% 90.10% 90.10% 100.00%
Adjusted Per Share Value based on latest NOSH - 820,679
31/03/18 31/03/17 31/03/16 31/03/15 31/12/13 31/12/12 31/12/11 CAGR
RPS 8.62 8.03 10.22 9.36 11.84 12.05 12.45 -5.71%
  YoY % 7.35% -21.43% 9.19% -20.95% -1.74% -3.21% -
  Horiz. % 69.24% 64.50% 82.09% 75.18% 95.10% 96.79% 100.00%
EPS -1.29 -3.06 -0.37 0.22 0.39 0.49 0.55 -
  YoY % 57.84% -727.03% -268.18% -43.59% -20.41% -10.91% -
  Horiz. % -234.55% -556.36% -67.27% 40.00% 70.91% 89.09% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.0878 0.0981 0.1514 0.0000 0.1104 0.1112 0.0982 -1.77%
  YoY % -10.50% -35.20% 0.00% 0.00% -0.72% 13.24% -
  Horiz. % 89.41% 99.90% 154.18% 0.00% 112.42% 113.24% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/18 31/03/17 31/03/16 31/03/15 31/12/13 31/12/12 31/12/11 CAGR
Date 30/03/18 31/03/17 31/03/16 31/03/15 31/12/13 31/12/12 30/12/11 -
Price 0.9500 0.8550 0.4850 0.6500 0.6550 0.6200 0.5300 -
P/RPS 1.42 1.38 0.61 0.90 0.67 0.63 0.41 21.98%
  YoY % 2.90% 126.23% -32.22% 34.33% 6.35% 53.66% -
  Horiz. % 346.34% 336.59% 148.78% 219.51% 163.41% 153.66% 100.00%
P/EPS -9.52 -3.61 -17.16 38.04 20.19 15.50 9.44 -
  YoY % -163.71% 78.96% -145.11% 88.41% 30.26% 64.19% -
  Horiz. % -100.85% -38.24% -181.78% 402.97% 213.88% 164.19% 100.00%
EY -10.51 -27.69 -5.83 2.63 4.95 6.45 10.59 -
  YoY % 62.04% -374.96% -321.67% -46.87% -23.26% -39.09% -
  Horiz. % -99.24% -261.47% -55.05% 24.83% 46.74% 60.91% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.40 1.13 0.41 0.00 0.72 0.68 0.52 17.16%
  YoY % 23.89% 175.61% 0.00% 0.00% 5.88% 30.77% -
  Horiz. % 269.23% 217.31% 78.85% 0.00% 138.46% 130.77% 100.00%
Price Multiplier on Announcement Date
31/03/18 31/03/17 31/03/16 31/03/15 31/12/13 31/12/12 31/12/11 CAGR
Date 21/05/18 29/05/17 02/06/16 27/05/15 28/02/14 28/02/13 28/02/12 -
Price 0.9400 1.0700 0.4850 0.5650 0.7350 0.6000 0.5400 -
P/RPS 1.41 1.72 0.61 0.78 0.75 0.61 0.42 21.37%
  YoY % -18.02% 181.97% -21.79% 4.00% 22.95% 45.24% -
  Horiz. % 335.71% 409.52% 145.24% 185.71% 178.57% 145.24% 100.00%
P/EPS -9.42 -4.52 -17.16 33.07 22.66 15.00 9.62 -
  YoY % -108.41% 73.66% -151.89% 45.94% 51.07% 55.93% -
  Horiz. % -97.92% -46.99% -178.38% 343.76% 235.55% 155.93% 100.00%
EY -10.62 -22.13 -5.83 3.02 4.41 6.67 10.39 -
  YoY % 52.01% -279.59% -293.05% -31.52% -33.88% -35.80% -
  Horiz. % -102.21% -212.99% -56.11% 29.07% 42.44% 64.20% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.38 1.41 0.41 0.00 0.81 0.66 0.53 16.54%
  YoY % -2.13% 243.90% 0.00% 0.00% 22.73% 24.53% -
  Horiz. % 260.38% 266.04% 77.36% 0.00% 152.83% 124.53% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS